Investor · St. Louis, MO

Rick L. Ryan

Open Rick in the network graph →

Filings

30

SEC Form D

Connections

97

co-filers

Capital

$33.0M

across filings

Active

Jun 2017

to May 2019

Most-connected co-filers (97)

Richard C. Breeden · Greenwich, CT14 shared Ivo R. Steklac · Boulder, CO14 shared Papef Vii GP, LLC · Darien, CT14 shared Adrian Tuck · Boulder, CO14 shared Portfolio Advisors, LLC · Darien, CT14 shared David Smoller · SAINT LOUIS, MO6 shared Clifford Holekamp · ST. LOUIS, MO5 shared Eduardo J. Martinez · St. Louis, MO4 shared Charles A. Bolten · St. Louis, MO4 shared Robert Beardsley · UNIVERSITY CITY, MO4 shared Robert J. Calcaterra · St. Louis, MO4 shared Cultivation Capital Life Sciences Fund II Manager, LLC · St. Louis, MO3 shared Ben Auspitz · DURHAM, NC3 shared Andrew F. Medvedev · New York, NY3 shared Arthur Reidel · San Martin, CA3 shared Gerald Fitch · Newport Coast, CA3 shared Bobby W. Sandage · St. Louis, MO3 shared David M. Mauro · Cambridge, MA3 shared Corey M. Goodman · Cambridge, MA3 shared Michael J. Powell · Billerica, MA3 shared Charles M. Yon · Cambridge, MA3 shared Arthur M. Krieg · Cambridge, MA3 shared C. R. Mullet · Reston, VA3 shared James M. Wilmott · New York, NY3 shared

Recent filings (30)

Cultivation Capital Life Sciences Fund II, LLCMay 2020 · 9 co-filers$30.0M Cultivation Capital Life Sciences Fund II, LLCMay 2020 · 9 co-filers$30.0M Cultivation Capital Life Sciences Fund II, LLCMay 2019 · 13 co-filers$30.0M Checkmate Pharmaceuticals, Inc.Apr 2019 · 26 co-filers$22.0M Checkmate Pharmaceuticals, Inc.Dec 2018 · 22 co-filers$22.0M Cultivation Capital Life Sciences Fund II, LLCMay 2018 · 13 co-filers$30.0M Bamboo Micro Opportunity Fund I, LPJul 2017 · 11 co-filers$20.0M Checkmate Pharmaceuticals, Inc.Jun 2017 · 21 co-filers$27.0M Bamboo Micro Opportunity Fund I, LPJun 2017 · 16 co-filers$20.0M Euclises Pharmaceuticals, Inc.Oct 2015 · 18 co-filers$1.9M Tabor Partners, LPJan 2015 · 9 co-filers Firefly BioWorks, Inc.Jul 2014 · 8 co-filers$1.5M JRD Partners II, LPMay 2014 · 5 co-filers$2.0M Tabor Partners, LPFeb 2014 · 9 co-filers Euclises Pharmaceuticals, Inc.Jan 2014 · 16 co-filers$1.4M Cultivation Capital Life Sciences Fund, LLCJun 2013 · 6 co-filers$30.0M Portfolio Advisors Private Equity Fund VII (Offshore), L.P.Apr 2013 · 5 co-filers Portfolio Advisors Private Equity Fund VII, L.P.Apr 2013 · 5 co-filers Portfolio Advisors Private Equity Fund VII, L.P.Mar 2013 · 5 co-filers Portfolio Advisors Private Equity Fund VII (Offshore), L.P.Mar 2013 · 5 co-filers Portfolio Advisors Private Equity Fund VII (Offshore), L.P.Feb 2013 · 5 co-filers Portfolio Advisors Private Equity Fund VII (Offshore), L.P.Oct 2012 · 5 co-filers Portfolio Advisors Private Equity Fund VII, L.P.Oct 2012 · 5 co-filers Portfolio Advisors Private Equity Fund VII (Offshore), L.P.Apr 2012 · 5 co-filers Portfolio Advisors Private Equity Fund VII, L.P.Apr 2012 · 5 co-filers

Derived from public SEC Form D (Reg D) filings; entities resolved probabilistically. See Rick in the interactive graph →